Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.

NCT02824354 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no participants enrolled

Conditions

Cirrhosis
Alcohol Dependence
Nalmefene

Interventions

DRUG: Nalmefene (Selincro®) 18 mg tablet
DRUG: placebo

Sponsor

Centre Hospitalier Universitaire, Amiens